Topical Propranolol Therapy for Infantile Hemangiomas
- 6 December 2011
- journal article
- Published by Wiley in Pediatric Dermatology
- Vol. 29 (2) , 154-159
Abstract
Abstract: The nonselective beta‐adrenergic receptor antagonist propranolol is an effective therapy for infantile hemangiomas. Systemic propranolol therapy shows a rapid therapeutic effect with good drug tolerability. We report on the efficacy of local application of propranolol ointment in superficial hemangiomas of the skin. In our outpatient department, 45 children with 65 hemangiomas were treated with 1% propranolol in a hydrophilic ointment topically applied twice a day. Before start of treatment and at each visit, clinical photographs were taken. If ultrasound did not confirm occult deeper components, children were included in the study. Treatment in the proliferative phase within the first 6 months of life (including seven preterm infants) induced regression in 59% and cessation of growth in 26% of the hemangiomas. No response or proliferation of subcutaneous components was observed in 15%. Clinically, no side effects caused by the beta‐receptor blocker were noticed. Treatment of two ulcerated hemangiomas of the perineal region twice using a flash lamp pulsed‐dye laser and propranolol ointment in the surrounding lesion led to healing of the ulcers in 3 and 6 weeks, respectively. In six patients, topical therapy was started between the ages of 7 and 33 months. Even in these hemangiomas, improvement was obvious after 2 or 3 months. Propranolol administered topically in 1% ointment could have a beneficial effect on superficial hemangiomas of the skin. The treatment was well tolerated without side effects even in preterm infants and in children with numerous or large lesions.Keywords
This publication has 21 references indexed in Scilit:
- Propranolol, a very promising treatment for ulceration in infantile hemangiomas: A study of 20 cases with matched historical controlsJournal of the American Academy of Dermatology, 2011
- Propranolol for Infantile HemangiomasPediatric Dermatology, 2011
- Oral Propranolol Therapy for Infantile Hemangiomas Beyond the Proliferation Phase: A Multicenter Retrospective StudyPediatric Dermatology, 2011
- Propranolol for complicated infantile haemangiomas: a case series of 30 infantsBritish Journal of Dermatology, 2010
- A Phase II, Open‐Label Study of the Efficacy and Safety of Imiquimod in the Treatment of Superficial and Mixed Infantile HemangiomaPediatric Dermatology, 2009
- Elastic Liposomes Mediated Transdermal Deliveryof an Anti-Hypertensive Agent: Propranolol HydrochlorideJournal of Pharmaceutical Sciences, 2007
- Corticosteroid treatment of periorbital haemangioma of infancy: a review of the evidenceBritish Journal of Ophthalmology, 2005
- Skin Toxicity of propranolol in guinea pigs.The Journal of Toxicological Sciences, 1999
- Relationship between the Amount of Propranolol Permeating through the Stratum Corneum of Guinea Pig Skin after Application of Propranolol Adhesive Patches and Skin Irritation.Biological and Pharmaceutical Bulletin, 1996
- Metabolism of Propranolol during Percutaneous Absorption in Human SkinJournal of Pharmaceutical Sciences, 1993